Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).
about
Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed ViremiaSafety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center.Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet: GeSida Study 8114.
P2860
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Executive summary of the GeSID ...... virus (updated January 2014).
@en
type
label
Executive summary of the GeSID ...... virus (updated January 2014).
@en
prefLabel
Executive summary of the GeSID ...... virus (updated January 2014).
@en
P2093
P50
P1476
Executive summary of the GeSID ...... y virus (updated January 2014)
@en
P2093
Antonio Antela
Bonaventura Clotet
Celia Miralles
Daniel Podzamczer
Esteban Martínez
Expert Panel of GeSIDA and the National Aids Plan
Fernando Lozano
Jaime Locutura
Jesús Santos
Jesús Sanz
P304
P356
10.1016/J.EIMC.2014.02.018
P50
P577
2014-06-28T00:00:00Z